期刊文献+

纳洛酮佐氨茶碱对早产儿原发性呼吸暂停的治疗作用

暂未订购
导出
摘要 目的评估纳洛酮佐氨茶碱与单用氨茶碱两组治疗早产儿呼吸暂停的疗效差异.方法59例患儿随机分成纳洛酮佐氨茶碱组30例,氨茶碱治疗组29例.结果用药后1h、1~24h、24~72h两组治疗效果在统计学上有显著性差异.结论佐用纳洛酮效果优于单用氨茶碱.
出处 《中原医刊》 2005年第17期14-15,共2页 Central Plains Medical Journal
  • 相关文献

参考文献6

二级参考文献16

  • 1孟庆林,胡长欣,候廷奎.盐酸纳洛酮拮抗乙醇中毒作用机理的探讨[J].中国急救医学,1996,16(3):2-4. 被引量:361
  • 2罗星照.纳络酮治疗婴儿窒息综合征[J].新药与临床,1988,(7):39-40.
  • 3Bhatia J. Current option in the management of apnea of prematurity [J]. Clin Pediatr. 2000, 39(6) :327-336.
  • 4Lee TC, Charles B, Steer P, et al. Population pharmacokinetics of intravenous caffeine in apnea of prematurity [J]. Clin Pharmacol Ther, 1997, 61:628-640.
  • 5Erenberg A, Leff R, Wynne B, et al. Results of the first double-blind placebo-controlled study of caffeine citrate for the treatment of apnea of prematurity(AOP) [J]. Pediatr. 1998, 102:756-757.
  • 6Comer AM, Perry CM, Figgitt DP. Caffeine citrate: a review of its use in apnea of prematurity [J]. Paediatr Drugs. 2001, 3(1):61-79.
  • 7Poets CF, Darraj S, Bohnhorst B. Effect of doxapram on episodes of apnea, bradycardia and hypoxaemia in preterm infants. Biol Neonate 1999, 76:207-213.
  • 8Sreenan C, Lemke RP, Hudson-Mason A, et al. High-flow nasal cannulae in the management of apnea of prematurity:a comparison with conventional nasal continuous positive airway pressure[J]. Pediatr. 2001, 107(5) :1081-1083.
  • 9Lemyre B, Davis PG, de Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity[J]. Cochrane Database Syst Rev. 2002, (1): CD002272.
  • 10Ibara S, Ikenoue T, Sameshima H, etal. The perinatal risk factors of periventricular leukomalacia(PVL) in premature infants. Nippon Sanka Fujinka Gakkai Zasshi, 1995,47(11) : 1243- 1245.

共引文献513

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部